Demystifying Merck & Co: Insights From 8 Analyst Reviews
Demystifying Merck & Co: Insights From 8 Analyst Reviews
揭秘默沙东公司：来自8位分析师评论的见解
The perception...Across the recent three months, 8 analysts have shared their insights on Merck & Co (NYSE:MRK), expressing a variety of opinions spanning from bullish to bearish.
在最近三个月中，8位分析师分享了他们对默沙东公司（纽约证券交易所代码：MRK）的见解，表达了从看涨到看跌的各种观点。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
下表汇总了他们最近的评级，阐明了过去30天内情绪的变化，并将其与前几个月进行了比较。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $144.12, a high estimate of $155.00, and a low estimate of $125.00. Observing a downward trend, the current average is 2.29% lower than the prior average price target of $147.50.
分析师通过对12个月目标股价的评估提供了更深入的见解，显示平均目标价为144.12美元，最高估计为155.00美元，低估值为125.00美元。从下降趋势来看，当前的平均价格比之前的平均目标价147.50美元低2.29％。
Deciphering Analyst Ratings: An In-Depth Analysis
解密分析师评级：深度分析
The perception...
通过...
登录免费看全文
登录/注册
资讯热榜
更新时间